Long Noncoding RNAs in the Pathogenesis of Insulin Resistance.
Wei-Li YangYixiang LyuRui XiangJichun YangPublished in: International journal of molecular sciences (2022)
Insulin resistance (IR), designated as the blunted response of insulin target tissues to physiological level of insulin, plays crucial roles in the development and progression of diabetes, nonalcoholic fatty liver disease (NAFLD) and other diseases. So far, the distinct mechanism(s) of IR still needs further exploration. Long non-coding RNA (lncRNA) is a class of non-protein coding RNA molecules with a length greater than 200 nucleotides. LncRNAs are widely involved in many biological processes including cell differentiation, proliferation, apoptosis and metabolism. More recently, there has been increasing evidence that lncRNAs participated in the pathogenesis of IR, and the dysregulated lncRNA profile played important roles in the pathogenesis of metabolic diseases including obesity, diabetes and NAFLD. For example, the lncRNAs MEG3, H19, MALAT1, GAS5, lncSHGL and several other lncRNAs have been shown to regulate insulin signaling and glucose/lipid metabolism in various tissues. In this review, we briefly introduced the general features of lncRNA and the methods for lncRNA research, and then summarized and discussed the recent advances on the roles and mechanisms of lncRNAs in IR, particularly focused on liver, skeletal muscle and adipose tissues.
Keyphrases
- insulin resistance
- long non coding rna
- type diabetes
- glycemic control
- skeletal muscle
- poor prognosis
- network analysis
- blood glucose
- adipose tissue
- high fat diet
- high fat diet induced
- polycystic ovary syndrome
- metabolic syndrome
- genome wide analysis
- genome wide identification
- gene expression
- cardiovascular disease
- long noncoding rna
- weight loss
- blood pressure
- cell proliferation
- weight gain
- body mass index
- signaling pathway
- ionic liquid
- amino acid
- protein protein